东盟疫苗能力调查（AVCS）-评估报告（英）-2025.1_29页_877kb

ASEAN Vaccine Capacity Survey (AVCS) Assessment Summary

Background: The ASEAN Vaccine Capacity Survey (AVCS), launched in 2023, builds upon the ASEAN Vaccine Baseline Survey (AVBS) conducted between 2017 and 2018. It aims to evaluate the region's vaccine capabilities, strengthen self-reliance, and improve epidemic responses under the ASEAN Vaccine Security and Self-Reliance (AVSSR) framework.

Key Objectives:

1. Collect precise data to guide the AVSSR plan (2021-2025).
2. Identify collaborative opportunities and challenges among member states.
3. Share findings through a regional information-sharing platform to enhance vaccine self-reliance.

Methods:

• Primary data collected via an Excel template.
• Secondary data from web resources and validated through teleconferences.
• Analysis focusing on production, distribution, R&D, regulations, and crisis management.

Survey Scope:
Data from 7 member states: Brunei, Indonesia, Laos, Malaysia, Philippines, Singapore, and Thailand. Key areas covered:

• Access & Decision-Making: Diverse mechanisms involve governments, health ministries, and advisory groups.
• Funding: Substantial investments in vaccines (e.g., COVID-19), research, and public procurement.
• NIP & AEFI Monitoring: Robust systems for adverse event surveillance and outbreak response.
• Supply Chains: Centralized distribution systems and digital tools like the Vaccine Management System.
• R&D & Production: Limited but growing capabilities, with 2 states producing vaccines and 3 conducting local R&D.
• Regulatory Framework: Compliance with international standards (e.g., GMP, WHO PQ) via NRAs and NCLs.

Challenges:

1. Insufficient research capacity and infrastructure.
2. Lack of specialized educational programs for vaccine-related fields.
3. Workforce shortages and limited public funding for vaccine production.
4. Dependence on external manufacturers for certain vaccines.

Recommendations:

1. Enhance training and regulatory frameworks.
2. Increase funding for R&D and technology transfer.
3. Expand local production facilities.
4. Foster regional and international partnerships.
5. Develop buffer stocks and contingency measures.

Conclusion:
The AVCS underscores ASEAN's commitment to improving vaccine self-reliance and regional cooperation for public health security. By addressing identified challenges and leveraging opportunities, the region aims to build a resilient vaccine ecosystem.

Summary Completion